Optimising zoledronate treatment holiday duration without loss of fracture prevention

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	217-219
Number of pages	3
Journal	The Lancet Diabetes and Endocrinology
Volume	12
Issue number	4
DOIs	https://doi.org/10.1016/S2213-8587(24)00064-0
State	Published - Apr 2024

ASJC Scopus subject areas

@article{8ea6e3fe18d54b60bfca6ed636cda22e,

title = "Optimising zoledronate treatment holiday duration without loss of fracture prevention",

author = "Drake, {Matthew T.}",

year = "2024",

month = apr,

doi = "10.1016/S2213-8587(24)00064-0",

language = "English (US)",

volume = "12",

pages = "217--219",

journal = "The Lancet Diabetes and Endocrinology",

issn = "2213-8587",

publisher = "Elsevier BV",

number = "4",

}

TY - JOUR

T1 - Optimising zoledronate treatment holiday duration without loss of fracture prevention

AU - Drake, Matthew T.

PY - 2024/4

Y1 - 2024/4

UR - http://www.scopus.com/inward/record.url?scp=85186659219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85186659219&partnerID=8YFLogxK

U2 - 10.1016/S2213-8587(24)00064-0

DO - 10.1016/S2213-8587(24)00064-0

M3 - Comment/debate

C2 - 38452785

AN - SCOPUS:85186659219

SN - 2213-8587

VL - 12

SP - 217

EP - 219

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

IS - 4

ER -